biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by KayakerBCon Dec 29, 2015 3:29pm

154 Views

Post# 24417547

RE:****fireworks****

is this a joke? why was the cashflow coming in the door not mentioned as a key highlight of 2015? would that not contribute to the exceptional year? it was spoken of back in july. must’ve been an oversight but thankfully I was thanked, yet again, for my contribution.

No, no one is thanking you for your contribution.

sounds to me like 2016 is going to be a lot like 2015, 2014 and 2013, lots of thanking, financing and waiting.

And whining and complaining.

Bullboard Posts

Barrick Gold employees detained in Mali amid ongoing dispute